| NDC Code | 0338-0143-02 |
|---|
| Package Description | 250 mL in 1 BAG (0338-0143-02) |
|---|
| Product NDC | 0338-0143 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Dextrose And Electrolyte No. 48 |
|---|
| Non-Proprietary Name | Sodium Lactate, Potassium Chloride, Magnesium Chloride, Monobasic Potassium Phosphate, Sodium Chloride And Dextrose Monohydrate |
|---|
| Dosage Form | INJECTION |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 19790202 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA017484 |
|---|
| Manufacturer | Baxter Healthcare Company |
|---|
| Substance Name | DEXTROSE MONOHYDRATE; SODIUM LACTATE; POTASSIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM CHLORIDE |
|---|
| Strength | 5; 260; 141; 31; 20; 12 |
|---|
| Strength Unit | g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL |
|---|
| Pharmacy Classes | Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] |
|---|